FDA Orange Book
Is there a generic for Exem Foam Kit?
Exem Foam Kit contains air polymer-type a. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Exem Foam Kit (air polymer-type a). The Orange Book shows its last listed patent expires February 11, 2036.
Run it in Rivvi
Map Exem Foam Kit and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Exem Foam Kit products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| foam, intrauterine | 10ML | Marketed (Rx) | None | 0 | None |
NDA 212279, held by GISKIT PHARMA BV. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Exem Foam Kit patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9034300 | October 15, 2030 | Drug product | U-2663 | 212279 |
| 9259494 | May 4, 2035 | Drug product | U-2663 | 212279 |
| 9849199 | February 11, 2036 | Drug product | None | 212279 |
Questions
Is there a generic for Exem Foam Kit?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Exem Foam Kit (air polymer-type a). The Orange Book shows its last listed patent expires February 11, 2036.
What is the generic name for Exem Foam Kit?
The active ingredient in Exem Foam Kit is air polymer-type a, per the FDA Orange Book.
When does the Exem Foam Kit patent expire?
The last patent listed for Exem Foam Kit in the Orange Book expires February 11, 2036. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.